Mexico's SMSP public health institute ready for greater influence
This article was originally published in Clinica
Executive Summary
Pablo Kuri Morales began his tenure as president of Mexico's public health institute, Sociedad Mexicana de Salud Pública, with the unveiling last week of its 2009-10 work plan. Its main aim is to strengthen its policy-generating influence and role as interlocutor between public health players (the document is available at: www.smsp.org.mx). The SMSP is a long-standing and influential non-governmental preventive healthcare policy body that ostensibly focuses on the under-covered segments of the population. Dr Kuri's medical and healthcare policy career has specialised in surgery (he is member of the national surgery academy) and epidemiological surveillance.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.